1. Home
  2. LGL vs CING Comparison

LGL vs CING Comparison

Compare LGL & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LGL Group Inc. (The)

LGL

LGL Group Inc. (The)

HOLD

Current Price

$5.70

Market Cap

31.6M

Sector

Technology

ML Signal

HOLD

CING

Cingulate Inc.

HOLD

Current Price

$4.34

Market Cap

26.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LGL
CING
Founded
1917
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.6M
26.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
LGL
CING
Price
$5.70
$4.34
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$31.33
AVG Volume (30 Days)
8.8K
131.8K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
149.85
N/A
EPS
0.17
N/A
Revenue
$4,107,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$33.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.45
$3.20
52 Week High
$9.74
$6.01

Technical Indicators

Market Signals
Indicator
LGL
CING
Relative Strength Index (RSI) 45.96 61.65
Support Level $5.57 $3.85
Resistance Level $5.90 $4.30
Average True Range (ATR) 0.20 0.27
MACD 0.01 0.02
Stochastic Oscillator 47.98 81.34

Price Performance

Historical Comparison
LGL
CING

About LGL LGL Group Inc. (The)

LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: